Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 2, 2007, Pages 740-743

  Bourgeois, Ingrid ^b   Pestel Caron, Martine ^a   Lemeland, Jean Francois ^b   Pons, Jean Louis ^b   Caron, Francois ^b  

^a UNIVERSITÉ DE ROUEN   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COAGULASE; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STAPHYLOCOCCUS LUGDUNENSIS;

ANTI-BACTERIAL AGENTS; COAGULASE; DRUG TOLERANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TEICOPLANIN; VANCOMYCIN;

EID: 33846562436     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00719-06     Document Type: Article

References (24)

1. Amsterdam, D. 2005. Susceptibility testing of antimicrobials in liquid media, p. 61-144. In V. Lorian (ed.), Antibiotics in laboratory medicine, 5th ed. Williams & Wilkins, Baltimore, MD.
2. Carbon, C. 2000. MRSA and MRSE: is there an answer? Clin. Microbiol. Infect. 6:(Suppl. 2)17-22.
3. Charpentier, E., and E. Tuomanen. 2000. Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect. 2:1855-1864.
4. Chu, V. H., C. H. Cabell, E. Abrutyn, G. R. Corey, B. Hoen, J. M. Miro, L. Olaison, M. E. Stryjewski, P. Pappas, K. J. Anstrom, S. Eykyn, G. Habib, N. Benito, and V. G. Fowler, Jr. 2004. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin. Infect. Dis. 39:1527-1530.
5. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing - 15th informational supplement. Approved standard, CLSI document M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2006. Communiqué 2006. Société Française de Microbiologie, Paris, France. http://www.sfm.asso.fr/.
7. Filipe, S. R., E. Severina, and A. Tomasz. 2002. The murMN operon: a functional link between antibiotic resistance and antibiotic tolerance in Streptococcus pneumoniae. Proc. Natl. Acad. Sci. USA 99:1550-1555.
8. Freney, J., Y. Brun, M. Bes, F. Meugnier, F. Grimont, P. A. D. Grimont, C. Nervi, and J. Fleurette. 1988. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int. J. Syst. Bacteriol. 38:168-172.
9. Hellbacher, C., E. Tornqvist, and B. Soderquist. 2006. Staphylococcus lugdunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates. Clin. Microbiol. Infect. 12:43-49.
10. Huang, C. R., C. H. Lu, J. J. Wu, H. W. Chang, C. C. Chien, C. B. Lei, and W. N. Chang. 2005. Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes. Infection 33:56-60.
11. Huebner, J., and D. A. Goldmann. 1999. Coagulase-negative staphylococci: role as pathogens. Annu. Rev. Med. 50:223-236.
12. Levine, D. P. 2006. Vancomycin: a history. Clin. Infect. Dis. 42:(Suppl. 1)S5-S12.
13. May, J., K. Shannon, A. King, and G. French. 1998. Glycopeptide tolerance in Staphylococcus aureus. J. Antimicrob. Chemother. 42:189-197.
14. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity antimicrobial agents. Approved guidelines. Document M26-A. National Committee for Clinical Laboratory Standards, Wayne, PA.
15. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard. Document M7, vol. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, PA.
16. Perry, J. D., A. L. Jones, and F. K. Gould. 1999. Glycopeptide tolerance in bacteria causing endocarditis. J. Antimicrob. Chemother. 44:121-124.
17. Peschel, A., C. Vuong, M. Otto, and F. Götz. 2000. The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob. Agents Chemother. 44:2845-2847.
18. Rice, K. C., B. A. Firek, J. B. Nelson, S. J. Yang, T. G. Patton, and K. W. Bayles. 2003. The Staphylococcus aureus cidAB operon: evaluation of its role in regulation of murein hydrolase activity and penicillin tolerance. J. Bacteriol. 185:2635-2643.
19. Sherris, J. C. 1986. Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob. Agents Chemother. 30:633-637.
20. Tomasz, A., A. Albino, and E. Zanati. 1970. Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 227:138-140.
21. Tuomanen, E., D. T. Durack, and A. Tomasz. 1986. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob. Agents Chemother. 30:521-527.
22. Vandenesch, F., J. Etienne, M. E. Reverdy, and S. J. Eykyn. 1993. Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin. Infect. Dis. 17:871-876.
23. Watanakunakorn, C. 1985. Antibiotic tolerance of Staphylococcus epidermidis. Scand. J. Infect. Dis. 17:59-61.
24. Yugueros, J., A. Temprano, M. Sanchez, J. M. Luengo, and G. Naharro. 2001. Identification of Staphylococcus spp. by PCR-restriction fragment length polymorphism of gap gene. J. Clin. Microbiol. 39:3693-3695.